Bladder Cancer: Transforming the Field

May 18-21, 2019
Grand Hyatt Denver
Denver, Colorado 

Conference Cochairs
Charles G. Drake, Columbia University Medical Center, New York, New York
Jason A. Efstathiou, Massachusetts General Hospital, Boston, Massachusetts
Donna E. Hansel, Oregon Health & Science University, Portland, Oregon
Dan Theodorescu, Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California
Ellen C. Zwarthoff, Erasmus Medical Center, Rotterdam, The Netherlands

Recent advances in large-scale gene expression and sequencing efforts, systemic immunotherapies, and the discovery of novel biomarkers are rapidly improving the clinical management of bladder cancer. This timely first special conference on bladder cancer will bring together scientists and physicians to discuss and relay important discoveries across the entire arc of the disease, from basic biology to survivorship. Special emphasis will be placed on integrating recent laboratory discoveries and technologies into clinical management of the disease.

Professional Educational Grants



Ferring Pharmaceuticals


Seattle Genetics

Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available